Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andriy Yabluchanskiy

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Drugs & Aging|October 10, 2019
Is Testosterone Replacement Therapy in Older Men Effective and Safe?Andriy Yabluchanskiy, Panayiotis D Tsitouras
Proteomics. Clinical Applications|July 22, 2014
Heavy hitting: Using water to label humansYonggang Ma, Andriy Yabluchanskiy, Merry L Lindsey
Fibrogenesis & Tissue Repair|June 5, 2013
Neutrophil roles in left ventricular remodeling following myocardial infarctionYonggang Ma, Andriy Yabluchanskiy, Merry L Lindsey
Geroscience|December 17, 2023
PCSK9: an emerging player in cardiometabolic aging and its potential as a therapeutic target and biomarkerAnna Csiszar, Stefano Tarantini, Andriy Yabluchanskiy, et al.
Frontiers in Genetics|October 17, 2019
Potential Adverse Cardiovascular Effects of Treatment With Fluoxetine and Other Selective Serotonin Reuptake Inhibitors (SSRIs) in Patients With Geriatric Depression: Implications for Atherogenesis and Cerebromicrovascular DysregulationZoltan Ungvari, Stefano Tarantini, Andriy Yabluchanskiy, et al.
Geroscience|October 24, 2019
Overexpression of catalase targeted to mitochondria improves neurovascular coupling responses in aged miceAnna Csiszar, Andriy Yabluchanskiy, Anna Ungvari, et al.
Current Drug Targets|January 16, 2013
Matrix metalloproteinases: drug targets for myocardial infarctionAndriy Yabluchanskiy, Yaojun Li, Robert J Chilton, et al.
Life Sciences|September 4, 2023
Protein kinase A: A potential marker of sympathovagal imbalance in heart failurePraloy Chakraborty, Sunny S Po, Andriy Yabluchanskiy, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2012
Is isolated systolic hypertension worse than combined systolic/diastolic hypertension?Yonggang Ma, Andriy Yabluchanskiy, Merry L Lindsey, et al.
Geroscience|August 20, 2021
Effect of genetic depletion of MMP-9 on neurological manifestations of hypertension-induced intracerebral hemorrhages in aged miceStefano Tarantini, Andriy Yabluchanskiy, Merry L Lindsey, et al.
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Drugs & Aging|October 10, 2019
Is Testosterone Replacement Therapy in Older Men Effective and Safe?Andriy Yabluchanskiy, Panayiotis D Tsitouras
Proteomics. Clinical Applications|July 22, 2014
Heavy hitting: Using water to label humansYonggang Ma, Andriy Yabluchanskiy, Merry L Lindsey
Fibrogenesis & Tissue Repair|June 5, 2013
Neutrophil roles in left ventricular remodeling following myocardial infarctionYonggang Ma, Andriy Yabluchanskiy, Merry L Lindsey
Geroscience|December 17, 2023
PCSK9: an emerging player in cardiometabolic aging and its potential as a therapeutic target and biomarkerAnna Csiszar, Stefano Tarantini, Andriy Yabluchanskiy, et al.
Frontiers in Genetics|October 17, 2019
Potential Adverse Cardiovascular Effects of Treatment With Fluoxetine and Other Selective Serotonin Reuptake Inhibitors (SSRIs) in Patients With Geriatric Depression: Implications for Atherogenesis and Cerebromicrovascular DysregulationZoltan Ungvari, Stefano Tarantini, Andriy Yabluchanskiy, et al.
Geroscience|October 24, 2019
Overexpression of catalase targeted to mitochondria improves neurovascular coupling responses in aged miceAnna Csiszar, Andriy Yabluchanskiy, Anna Ungvari, et al.
Current Drug Targets|January 16, 2013
Matrix metalloproteinases: drug targets for myocardial infarctionAndriy Yabluchanskiy, Yaojun Li, Robert J Chilton, et al.
Life Sciences|September 4, 2023
Protein kinase A: A potential marker of sympathovagal imbalance in heart failurePraloy Chakraborty, Sunny S Po, Andriy Yabluchanskiy, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2012
Is isolated systolic hypertension worse than combined systolic/diastolic hypertension?Yonggang Ma, Andriy Yabluchanskiy, Merry L Lindsey, et al.
Geroscience|August 20, 2021
Effect of genetic depletion of MMP-9 on neurological manifestations of hypertension-induced intracerebral hemorrhages in aged miceStefano Tarantini, Andriy Yabluchanskiy, Merry L Lindsey, et al.
Pageof 19